So, if the US simply follows Japan and sells $239m at say only 50% profit, that equates to $119m profit per annum, divided by 1.5B shares and times a PE multiple of 10 = $0.79 per share. And that's ultra conservative based on only a PE of 10, only 50% profit, not taking into account a 3 times US population, and not giving any value whatsoever to BOT's successful pipeline in the background.
Dare to dream of a more likely biotech PE of 20 times ($1.60/share), BOT selling three times as well as Japan because of higher population ($4.80), the year-on-year growth, PLUS just one product from the pipeline to achieve FDA approval, and we're easily looking at +$5 within a few short years! But I doubt BOT will get that far before being taken out by big pharma. Hard not to be excited about BOT!
- Forums
- ASX - By Stock
- BOT
- BOT - Anything but charting
BOT - Anything but charting, page-6667
-
-
- There are more pages in this discussion • 2,252 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
34.5¢ |
Change
-0.020(5.48%) |
Mkt cap ! $543.4M |
Open | High | Low | Value | Volume |
35.5¢ | 35.5¢ | 34.0¢ | $4.566M | 13.13M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
11 | 410003 | 34.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
35.0¢ | 346713 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 403003 | 0.345 |
16 | 304864 | 0.340 |
12 | 887560 | 0.335 |
25 | 2286069 | 0.330 |
5 | 853843 | 0.325 |
Price($) | Vol. | No. |
---|---|---|
0.350 | 346713 | 8 |
0.355 | 48198 | 4 |
0.360 | 261992 | 7 |
0.365 | 522058 | 4 |
0.370 | 319527 | 7 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online